Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Sanitation Practices That We Will Stick With After COVID

The initial response to COVID saw a massive increase in the use of disinfectants across a wide spectrum of operations, everything from retail, transportation, hospitality, and healthcare to gymnasiums and restaurants introduced programs with intensive disinfection. People who were not routinely disinfecting surfaces put in place protocols to disinfect after every use, or moved from…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Sanitation Practices That We Will Stick With After COVID

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

The initial response to COVID saw a massive increase in the use of disinfectants across a wide spectrum of operations, everything from retail, transportation, hospitality, and healthcare to gymnasiums and restaurants introduced programs with intensive disinfection. People who were not routinely disinfecting surfaces put in place protocols to disinfect after every use, or moved from sanitizing to disinfection. The first impact of this was an immediate shortage of disinfectants and the materials to apply the disinfectants on a global basis. Many products especially ready to use wipes and liquids were simply unobtainable.

The good news is that over the past few months global supplies of disinfectants are now matching demand and supplies of most disinfectants are now widely available on the market we are also reevaluating what is being disinfected and how often. The CDC recently published guidelines that suggested the frequency of disinfection may be too high, the document has a number of flaws but it suggests that cleaning with a detergent routinely and only using disinfectants after an infected person has visited, the obvious problem being that we do not always know when an infected individual has visited our premises.

One thing that has had a significant impact on the market during COVID is the wide spread use of electrostatic spraying devices to apply disinfectant. These sprayers are very efficient at applying disinfectant over wide areas and can effectively cover a large area quickly, often using significantly less chemical than traditional methods such as cloths and mops. It is likely that the adoption of these devices will continue into the future as people see the benefits of being able to disinfect with such ease.

When supply chains are stressed, and products are in short supply people often look to alternative means and products. Before COVID hospitals and long term care facilities were typically very conservative in selection of disinfecting products and it could take many months to make a decision on the product that would be used. During the COVID outbreak we saw a lot of people switching to new and novel products such as NaDCC tablets, these have advantages over liquid disinfectants from a shipping and handling perspective and the ability of a few tablets to make a lot of disinfectant. Tablets have become one of the new items on the list of effective disinfectants that offer a broad spectrum of efficacy with minimal damage.

One area that has very much come to light in 2020 to 2021 is the lack of a significant flu season this year, a combination of mask wearing, hand hygiene and surface disinfection appears to have reduced the flu season to less than one tenth of normal. If we are willing to continue these practices especially in high risk areas such as schools and universities then we may have inadvertently created a solution for what had been a long term challenge. To continue with disinfection long term in schools, long term care, and daycare centers may require a financial commitment we are not ready to make but potentially we have the ability to reduce the impact of flu.

As the COVID risk subsides and restaurants are opening we see that traditional sanitizers as being replaced with disinfectants, sometimes it is similar chemistry just at a higher strength. This may well have an impact on the health and safety of the people applying the chemistry, and again the use of electrostatics provides options for use of chemistry that is less harmful than some of the legacy chemistries such as quaternary ammonium compounds.

There have been a few reports of people being impacted by the use of cleaning agents and disinfectants, with reports to poison centers doubling, typically when investigated these reports are people misusing disinfectants, one example was mixing bleach and vinegar in a residential setting, clearly and inappropriate use of both products. Perhaps one of the impacts could be to get people to actually read and follow the instructions on the label, but also switching overall to safer products to reduce health risks.

It is unlikely that many sectors that started with intensive disinfection, after each customer, after each class, after each occupant, after each flight, or even daily will continue with the practice, the cost benefit does not make sense to the individual business. From a public health perspective addressing pathogens that can remain viable on a surface for period of days though disinfection will always help to reduce infection, we should encourage the continued use of disinfection of surfaces over the longer term even if it is not needed for COVID. As we look over the landscape of the challenges we face even when COVID has finally gone there are other hazards to address MRSA in gymnasiums, Norovirus in cruise line and restaurants and influenza in schools will still be with us, the difference is that we have new equipment such as electrostatic sprayers and new chemistries such as NaDCC tablets to help address those challenges.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

Waiting for perfectly clean data is stalling healthcare AI, not protecting it

Healthcare organizations often delay AI initiatives waiting for perfectly clean data, but this assumption no longer holds: reliable subsets and synthetic data allow projects to start now while data work continues in parallel. Success requires starting with business outcomes rather than technology capabilities, and embedding governance in product strategy before implementation, not after.

  • 01Waiting for 100% clean data is effectively a decision never to start; hospital AI projects can begin on reliable data subsets while quality work continues in parallel.
  • 02Frame AI decisions around business outcomes (revenue growth, cost reduction, competitive advantage, new products, or ecosystem influence) rather than asking what AI can do.
  • 03Governance should be part of product strategy before design or purchase, especially as agentic AI takes actions—such as handling many revenue-cycle denials—while routing the rest to humans.

Sep 21, 2026

July partnerships show hospitals aligning without ownership change

July partnerships show hospitals aligning without ownership change

A July McDermott Will & Schulte analysis and four July partnership announcements tracked by Becker’s Hospital Review point to affiliation models that stop short of mergers. St. Christopher’s signed a nonbinding letter of intent with Nemours, Jefferson and Temple; Palomar UC San Diego Health began operating July 1 under a joint powers authority. Several announcements explicitly rule out ownership change, shifting the work to contracts covering governance and other terms.

  • 01In an alliance, the contract does the integrating that an org chart does in a merger: McDermott Will & Schulte says governance design, exclusivity, antitrust review, community commitments and exit rights all have to be settled before signing.
  • 02Purchasing is now explicitly on the table in at least one no-ownership deal, the St. Peter's Health and Billings Clinic-Logan Health talks in Montana, which means shared supply contracts can arrive without a change of control.

Sep 19, 2026

Eye telemedicine hits limits without home retinal imaging

Eye telemedicine hits limits without home retinal imaging

An Ophthalmology Times commentary by T.Y. Alvin Liu, Ferdinand Hui and Phillip Phan sorts eye patients into three telemedicine tiers by clinical need. Patients needing regular OCT scans benefit less unless a home device can send the image. Video tools already sit inside Epic and Cerner; the deciding purchase for retina clinics is the imaging device in the patient's living room.

  • 01The dividing line for eye telemedicine is imaging, not video: patients who need regular OCT scans benefit less from remote visits unless a device at home can send the scan, so a video license alone shifts few of those encounters.
  • 02The provider-side requirement, a HIPAA-compliant secured video platform, was already built into Epic and Cerner by 2020; the patient-side requirements (1.5 MB up and down bandwidth, a quiet private room, comfort with the technology) sit outside the health system's control and are the ones worth screening for at scheduling.
  • 03Self-administered home color fundus photography for tracking non-proliferative diabetic retinopathy was named as the nearer route into retina telemedicine; home OCT for wet AMD is the harder gate and the device to watch.

Sep 19, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512